State Of Wisconsin Investment Board Crinetics Pharmaceuticals, Inc. Transaction History

State Of Wisconsin Investment Board

$37.8 Billion
Q3 2024

A detailed history of State Of Wisconsin Investment Board transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 65,394 shares of CRNX stock, worth $3.62 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

65,394

Previous 60,416 8.24%

Holding current value

$3.62 Million

Previous $2.71 Million 23.43%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$43.83 - $54.98 $218,185 - $273,690	4,978 Added 8.24%	65,394 $3.34 Million
Q2 2024 Aug 14, 2024	BUY	$42.12 - $51.91 $434,046 - $534,932	10,305 Added 20.56%	60,416 $2.71 Million
Q1 2024 May 14, 2024	SELL	$34.76 - $46.81 $266,157 - $358,424	-7,657 Reduced 13.25%	50,111 $2.35 Million
Q4 2023 Feb 12, 2024	BUY	$25.62 - $37.07 $192,047 - $277,876	7,496 Added 14.91%	57,768 $2.06 Million
Q3 2023 Nov 14, 2023	BUY	$15.97 - $30.59 $173,657 - $332,635	10,874 Added 27.6%	50,272 $1.5 Million
Q2 2023 Aug 14, 2023	BUY	$15.73 - $23.6 $72,845 - $109,291	4,631 Added 13.32%	39,398 $709,000
Q1 2023 May 15, 2023	SELL	$15.31 - $21.1 $15,723 - $21,669	-1,027 Reduced 2.87%	34,767 $558,000
Q4 2022 Feb 14, 2023	SELL	$15.49 - $19.05 $35,673 - $43,872	-2,303 Reduced 6.05%	35,794 $655,000
Q3 2022 Nov 14, 2022	BUY	$18.11 - $22.37 $27,653 - $34,158	1,527 Added 4.18%	38,097 $748,000
Q2 2022 Aug 15, 2022	SELL	$16.49 - $27.64 $407,797 - $683,537	-24,730 Reduced 40.34%	36,570 $682,000
Q1 2022 May 13, 2022	SELL	$17.15 - $28.31 $118,334 - $195,339	-6,900 Reduced 10.12%	61,300 $1.35 Million
Q4 2021 Feb 11, 2022	BUY	$19.35 - $28.41 $572,760 - $840,936	29,600 Added 76.68%	68,200 $1.94 Million
Q4 2020 Feb 03, 2021	SELL	$12.08 - $17.46 $57,984 - $83,808	-4,800 Reduced 11.06%	38,600 $545,000
Q3 2020 Nov 16, 2020	BUY	$13.62 - $17.66 $358,206 - $464,458	26,300 Added 153.8%	43,400 $680,000
Q1 2020 May 06, 2020	BUY	$11.52 - $26.46 $5,760 - $13,230	500 Added 3.01%	17,100 $251,000
Q3 2019 Nov 12, 2019	BUY	$14.91 - $25.01 $102,879 - $172,569	6,900 Added 71.13%	16,600 $250,000
Q2 2019 Aug 14, 2019	BUY	$21.48 - $27.71 $4,296 - $5,542	200 Added 2.11%	9,700 $242,000
Q1 2019 May 13, 2019	BUY	$21.07 - $29.31 $44,247 - $61,551	2,100 Added 28.38%	9,500 $216,000
Q4 2018 Feb 11, 2019	BUY	$22.4 - $35.39 $165,760 - $261,886	7,400 New	7,400 $222,000

Others Institutions Holding CRNX

# of Institutions

242

Shares Held

79.6M

Call Options Held

23.3K

Put Options Held

44.3K

View Full List

About Crinetics Pharmaceuticals, Inc.

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.98B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

More about CRNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account

State Of Wisconsin Investment Board Crinetics Pharmaceuticals, Inc. Transaction History